Comparison
5p Partial Monosomy Syndrome C0010314 vs 2 Hydroxyphenylacetic Aciduria C5937087
Clinical comparison between 5P Partial Monosomy Syndrome and 2 Hydroxyphenylacetic Aciduria for differential diagnosis and treatment planning.
5p Partial Monosomy Syndrome C0010314
Also called Cri-du-chat syndrome, caused by a deletion on chromosome 5. Features include a high-pitched cry, developmental delay, and intellectual disability.
2 Hydroxyphenylacetic Aciduria C5937087
A rare metabolic disorder where the body cannot properly process certain acids. It may cause neurological issues and is typically identified in infancy. Management involves diet modifications and supportive care.
6 comparison axes
Onset
5p Partial Monosomy Syndrome C0010314
0-0
2 Hydroxyphenylacetic Aciduria C5937087
0-null
Onset patterns differ
Severity
5p Partial Monosomy Syndrome C0010314
severe
2 Hydroxyphenylacetic Aciduria C5937087
moderate
Different severity levels
Chronic
5p Partial Monosomy Syndrome C0010314
Chronic
2 Hydroxyphenylacetic Aciduria C5937087
Chronic
Differing course
Communicable
5p Partial Monosomy Syndrome C0010314
No
2 Hydroxyphenylacetic Aciduria C5937087
No
Different transmission
Body System
5p Partial Monosomy Syndrome C0010314
congenital
2 Hydroxyphenylacetic Aciduria C5937087
metabolic
Same/different system
Category
5p Partial Monosomy Syndrome C0010314
genetic
2 Hydroxyphenylacetic Aciduria C5937087
metabolic
Different category
Bottom line
5p-partial-monosomy-syndrome-C0010314 and 2-hydroxyphenylacetic-aciduria-C5937087 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 5p Partial Monosomy Syndrome C0010314 | 2 Hydroxyphenylacetic Aciduria C5937087 | Discriminating power |
|---|---|---|---|
| High-pitched cry | Characteristic cry is described in Cri-du-chat syndrome. | Not described in the supplied source. | High |
| Developmental or neurological features | Developmental delay and intellectual disability are typical features. | Neurological issues may occur; specific pattern is not established. | Moderate |
| Metabolic presentation | Not a primary metabolic acid-processing disorder in the source. | Impaired processing of certain acids, usually recognized in infancy. | High |
When to favor each condition
Choose 5p Partial Monosomy Syndrome C0010314 when
Congenital features with a high-pitched cry
This pattern aligns with chromosome 5 deletion rather than aciduria.
High
Suspected genetic syndrome from birth
Onset is congenital and the category is genetic.
High
Need to explain severe developmental disability
Source severity is severe, but individual course varies.
Moderate
Choose 2 Hydroxyphenylacetic Aciduria C5937087 when
Infancy with suspected metabolic disease
The source describes identification in infancy and acid-processing impairment.
Moderate
Abnormal organic acid finding needs context
An abnormal result is not itself a diagnosis and needs clinician review.
High
Diet and supportive care are being considered
Management is described as dietary modification plus supportive care.
Moderate
How key tests differ
| Test | 5p Partial Monosomy Syndrome C0010314 | 2 Hydroxyphenylacetic Aciduria C5937087 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May show deletion involving chromosome 5p. | Not expected to establish this metabolic condition. | A confirmed deletion supports the left diagnosis; absence does not diagnose the right. |
| Urine organic acid analysis | No characteristic aciduria is established by the source. | May show elevated 2-hydroxyphenylacetic acid; cutoff not supplied. | An abnormal metabolite is a finding requiring metabolic confirmation. |
| Developmental assessment | Often documents delay and intellectual disability. | May show neurological effects, but pattern is not established. | Assessment supports care planning but does not distinguish etiology alone. |
Prognosis comparison
5p Partial Monosomy Syndrome C0010314
- Outcome
- Chronic congenital condition with developmental disability; exact prognosis is not established here.
- Factors
- Deletion extent, associated anomalies, and support services may influence outcome.
2 Hydroxyphenylacetic Aciduria C5937087
- Outcome
- Chronic metabolic condition with possible neurological effects; outcome data are sparse.
- Factors
- Age at recognition, metabolic control, and supportive care may matter, but evidence is limited.
Time frame: Lifelong follow-up is generally relevant; precise timelines are not established.
Clinician interpretation should integrate genetics, metabolic testing, development, and comorbidities.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurodevelopment | Developmental delay and intellectual disability are core features. Neurological issues may occur; severity is not fully defined. Both need developmental follow-up; exact outcomes are not established here. |
| Feeding or metabolic stress | Not specifically established in the supplied description. Diet modification may be needed because acid processing is impaired. Dietary advice should come from a metabolic clinician. |
| Long-term support needs | Severe chronic congenital condition may require ongoing support. Moderate chronic course may still need supportive care. Individual needs vary and should not be inferred from labels alone. |
Patient education highlights
- HighDifferent causes
One is a chromosome deletion; the other is a rare metabolic disorder. Neither is communicable.
- HighTest meaning
A metabolite abnormality or developmental finding needs confirmation and does not by itself prove a diagnosis.
- MediumCare planning
Ask about genetics, metabolic evaluation, therapies, and nutrition rather than relying on general severity labels.